Cardlytics Capital Expenditures (CapEx) Growth & History (CDLX)

Cardlytics's capital expenditures (capex) was $480,000 for fiscal 2025.

View full Cardlytics company overview

Cardlytics annual capital expenditures (capex) history

Cardlytics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$480,000−$1.1M−69.27%
20242024-12-31$1.6M$895,000+134.18%
20232023-12-31$667,000−$504,000−43.04%
20222022-12-31$1.2M−$1.9M−62.32%
20212021-12-31$3.1M−$2.3M−42.53%
20202020-12-31$5.4M−$2.9M−34.66%
20192019-12-31$8.3M$2.4M+39.81%
20182018-12-31$5.9M$4.7M+387.24%
20172017-12-31$1.2M−$612,000−33.50%
20162016-12-31$1.8M

Cardlytics capital expenditures (capex) trends

Over the last five fiscal years, Cardlytics's capital expenditures (capex) decreased from $5.4M to $480,000, a change of −$4.9M. The latest reported quarter, Q2 2026, shows $2,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardlytics source filings ↗

Community posts

It’s quiet here.

No posts about CDLX yet. Start the conversation.

Write the first post